ZEQLUMO
Live / Allowed — Third extension granted (statement of use) (as of 02 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Aug 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98719344
- Mark type
- Word mark
- Filed
- 27 Aug 2024
- Published for opposition
- 01 Apr 2025
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 03 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Oct 2026 — SOU EXTENSION 3 GRANTED
- 02 Oct 2026 — SOU EXTENSION 3 FILED
- 02 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Apr 2026 — SOU EXTENSION 2 GRANTED
- 22 Apr 2026 — SOU EXTENSION 2 FILED
- 22 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2025 — SOU EXTENSION 1 GRANTED
- 03 Oct 2025 — SOU EXTENSION 1 FILED
- 03 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED